Results 81 to 90 of about 3,127 (178)

Leveraging topological indices and machine learning for advanced prediction of antidepressant drug properties. [PDF]

Sci Rep
Zhang G, Noureen S, Azam S, Abdalla MEM, Dafaalla ME, Aslam A, Tola KA.   +6 more
europepmc   +1 more source

Transformation of nomifensine using ionizing radiation and exploration of its anticancer effects in MCF-7 cells. [PDF]

Exp Ther Med, 2022
Kang SH, Bak DH, Yeoup Chung B, Bai HW.
europepmc   +1 more source

Ex vivo Drug Metabolism Using Primary Human Hepatocytes for the Detection of Metabolite-Dependent Antibodies to Red Blood Cells. [PDF]

Transfus Med Hemother
Mayer B, Kurth F, Damm G, Seehofer D, Salama A.   +4 more
europepmc   +1 more source

Norepinephrine release in the cerebellum contributes to aversive learning. [PDF]

Nat Commun, 2023
Stanley AT, Post MR, Lacefield C, Sulzer D, Miniaci MC.   +4 more
europepmc   +1 more source

Phasic dopamine release in two different rat models of attention-deficit/hyperactivity disorder: Spontaneously hypertensive rats (SHR) versus Lphn3 knockout rats. [PDF]

Neuroscience
Sable HJK, Paige NB, Nalan PA, Pace RL, Hicks CB, Regan SL, Williams MT, Vorhees CV, Lester DB.   +8 more
europepmc   +1 more source

Monoamine Oxidase Inhibitors Present in Tobacco Modulate Dopamine Balance Via the Dopamine Transporter. [PDF]

ACS Chem Neurosci
Saro G, Johne S, Latino DARS, Moine F, van der Toorn M, Mathis C, Veljkovic E.   +6 more
europepmc   +1 more source

Implication of synaptotagmins 4 and 7 in activity-dependent somatodendritic dopamine release in the ventral midbrain. [PDF]

Open Biol, 2022
Delignat-Lavaud B, Ducrot C, Kouwenhoven W, Feller N, Trudeau LÉ.   +4 more
europepmc   +1 more source

Mutational effects of the asparagine198 and glutamate223 residues on the human norepinephrine transporter on basal and HIV-1 Tat protein-induced inhibition of dopamine transport. [PDF]

Eur J Pharmacol
Porter KD, Adeniran C, Jimenez-Torres AC, Pless KL, Cirincione AB, Davenport H, Chen C, Zhan CG, Zhu J.   +8 more
europepmc   +1 more source

Reduced striatal dopamine transmission as a transdiagnostic substrate of psychomotor retardation. [PDF]

Brain
Leong IL, Ng TH, Sen K, Burchill E, Costello H, Badenoch JB, Coebergh J, McCutcheon RA, Nair A, Browning M, Huys QJM, Lewis G, Lees A, David AS, Rogers JP.   +14 more
europepmc   +1 more source

A Mouse Model of Nigrostriatal Dopaminergic Axonal Degeneration As a Tool for Testing Neuroprotectors. [PDF]

Acta Naturae, 2021
Kolacheva AA, Ugrumov MV.
europepmc   +1 more source